Description
Recombinant human monoclonal antibody against SARS-CoV-2 Nucleocapsid protein. This product is produced in Nicotiana benthamiana plants for use in Western blot and ELISA applications.
Target
SARS CoV-2 Nucleocapsid Protein
Target Alias Names
COVID-19 N-Protein antibody, COVID-19 Nucleocapsid Protein antibody, COVID-19 anti-N antibody, CBT_A0010, Nucleocapsid protein, Nucleocapsid
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
Yes
Original Discovery Method
Unknown
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression